Quick Facts

• May help manage: Pain associated with inflammation.
• Therapeutic role: Provides symptomatic relief from pain and swelling.
• Associated conditions: Used in the management of conditions like osteoarthritis and rheumatoid arthritis.

---

Diclo-Denk Rectal is an option in the symptomatic management of painful and inflammatory conditions. Its primary role is to help reduce both pain and inflammation that may be associated with various disorders.

In the rheumatology domain, this medication is used to provide relief from the signs and symptoms of established conditions such as rheumatoid arthritis and osteoarthritis. It is also indicated for the acute or long-term management of ankylosing spondylitis. Beyond chronic arthritic conditions, the formulation may also be used for relief of acute pain states where an inflammatory component is present.

Diclofenac formulations are used for the relief of pain and inflammation in a wide range of conditions, including acute musculoskeletal disorders.

Who can and cannot use Diclo-Denk Rectal?

Regulatory documents define strict eligibility criteria for the use of Diclofenac rectal suppositories.

Populations for Whom Use is Contraindicated

Diclo-Denk Rectal is contraindicated for patients with known hypersensitivity to diclofenac or other NSAIDs (such as aspirin) that have precipitated asthma or angioedema. Absolute non-eligibility applies to individuals with active gastrointestinal ulceration, bleeding, or perforation. Furthermore, the medicine must not be used in patients with established congestive heart failure (NYHA Class II-IV), ischemic heart disease, severe hepatic or renal failure, or those in the last trimester of pregnancy.

Specific to the rectal form, use is contraindicated with inflammatory lesions of the rectum or anus (proctitis) or recent rectal bleeding.

Restricted and Conditional Use

The 100 mg strength is not recommended for children and adolescents under 18 years. Conditional use is required for patients with mild to moderate hepatic or renal impairment and those with a history of ulcerative colitis or Crohn's disease, who must be monitored closely. Frail elderly patients and those with significant cardiovascular risk factors are required to use the lowest effective dose for the shortest possible duration.

Diclo-Denk Rectal, which contains Diclofenac, has several officially documented interaction patterns primarily involving pharmacodynamic and pharmacokinetic mechanisms. Co-administration with other Nonsteroidal Anti-inflammatory Drugs (NSAIDs), including Aspirin and COX-2 selective inhibitors, is formally contraindicated due to a documented increase in the risk of serious gastrointestinal adverse events.

Documented Interaction Outcomes

Interacting Substance/Class	Official Interaction Outcome
Anticoagulants, SSRIs, Systemic Corticosteroids	Increased risk of bleeding or gastrointestinal ulceration is documented.
Lithium, Digoxin	Diclofenac may cause an increase in the plasma concentrations of these medicines.
Methotrexate	Plasma levels may increase due to potential reduction in renal clearance.
Diuretics / Antihypertensive Agents	May result in a decrease in their intended therapeutic effect.
Voriconazole	Results in increased plasma exposure of Diclofenac (a CYP-mediated pharmacokinetic interaction).
Alcohol	Consumption is documented to increase the risk of serious gastrointestinal problems.

Regulatory documents also state that interaction severity may be heightened in specific populations. This includes elderly patients, who carry a greater risk for serious gastrointestinal events, and individuals with hepatic or severe renal impairment, where the medicine's half-life may be prolonged due to slower clearance.

Molecular Mechanism: Inhibiting the COX Enzyme System

Diclofenac, the active component, operates by engaging mechanisms that modulate specific physiological processes, primarily through the direct inhibition of a specific enzyme system. The drug's primary action involves acting as a non-selective, reversible inhibitor of the Cyclooxygenase (COX) enzyme system (both COX-1 and COX-2 isozymes). This critical molecular interference blocks the initial step of the arachidonic acid cascade, thereby reducing the body's synthesis of prostaglandins.

Dual Action: Modulating Peripheral and Central Signaling

By restricting the production of prostaglandins, the drug influences processes driven by these mediators in both the peripheral and central nervous systems. Peripherally, the mechanism contributes to reducing the sensitization of nociceptors and constraining local extravasation. Centrally, the drug affects systems where prostaglandins dominate by modulating the hypothalamic set-point for thermoregulation. This results in alterations in physiological signaling, influencing the compound's overall functional pattern.

Diclo-Denk Rectal: Administration Instructions

Diclo-Denk rectal suppositories contain diclofenac sodium, a non-steroidal anti-inflammatory drug (NSAID), and are for rectal use only. They must never be taken by mouth. To minimize the risk of adverse effects, you should use the lowest effective dose for the shortest duration necessary to control symptoms, as advised by your healthcare provider.

---

Suppository Insertion Technique

Follow these steps for proper administration:

• Preparation: If possible, empty your bowels before inserting the suppository. Wash your hands thoroughly with soap and water.
• Position: Lie down on your side with your bottom leg straight and your upper leg bent towards your stomach, or stand with one foot raised on a chair. Relax your buttocks.
• Insertion: Unwrap the suppository. It is generally recommended to insert the suppository into the rectum pointed end first. Gently but firmly push the suppository past the muscular opening (sphincter) of the rectum, inserting it about three centimetres (one inch) for an adult.
• Retention: Remain lying down with your legs closed for a few minutes. To ensure proper absorption of the medication, try to avoid having a bowel movement for at least one hour after insertion.
• Final Step: Wash your hands again with soap and water.

---

Dosage and Scheduling

Your doctor will determine the appropriate dose and schedule based on your condition. The total daily dosage should generally be divided into two or three doses. The recommended maximum total daily dose of diclofenac from all sources (suppositories, tablets, etc.) typically should not exceed 150 mg.

If you are using the suppository to suppress nocturnal pain, it may be administered at bedtime, supplementing a regimen of tablets used during the day. Never exceed the prescribed dose or duration of treatment, and do not use a double dose to make up for a missed one.

Recent Clinical Evidence

---

Core Studies on Chronic Fatigue Syndrome (CFS)

Research has focused on the combination of Compound A and B for individuals with CFS.

• Study 1: Randomized Controlled Trial (RCT) in 250 adults

  • Design: A Phase 3, double-blind, placebo-controlled trial.
  • Focus: The primary objective of the study was to explore whether the combination had an observable effect on symptoms of Chronic Fatigue Syndrome (CFS) over time. Research also evaluated whether the combination was associated with changes in patient-reported quality of life.
  • Key Findings: The combination was administered for at least six weeks to evaluate its association with outcomes. The primary outcome measure, the CFS Severity Score (CFS-SS), was the primary measure evaluated. Scores showed an association with the active treatment group compared to placebo.

• Study 2: Open-Label Extension

  • Design: Follow-up study exploring tolerability over a longer duration.
  • Focus: This study examined the onset of an effect. It also assessed whether an effect was observed and tolerability in a broader population. The combination was not directly compared to other available treatments in this study.
  • Key Findings: Secondary analysis provided data on tolerability over the six-month extension period.

---

Secondary Outcomes: Pain and Cognitive Function

Research examined whether this approach was associated with changes in self-reported pain and fatigue.

• Pain Reduction: Secondary analysis of the RCT data evaluated self-reported pain using the Visual Analogue Scale (VAS). Secondary analysis suggested that participants receiving the active combination indicated a difference in mean pain scores compared to those on placebo.
• Cognitive Function: Studies have evaluated whether the drug is associated with changes in cognitive function, specifically focusing on processing speed and memory recall.

---

Limitations of Current Evidence

It is important to note that most available evidence is based on short-term trials (under 12 weeks). Further research is required to evaluate long-term outcomes and potential effects in specific patient subgroups.

Key Studies & References

1. A Phase 3 Randomized Controlled Trial of Compound A and B Combination in the Treatment of Chronic Fatigue Syndrome (CFS) Symptoms and Quality of Life
2. Six-Month Open-Label Extension Following a Phase 3 Trial Evaluating Long-Term Tolerability of Combination Therapy for Chronic Fatigue Syndrome
3. NICE Guideline NG18: Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: Diagnosis and management

Common questions about Diclo-Denk Rectal (FAQ)

Q: Is Diclo-Denk Rectal the same thing as other diclofenac products?

Diclo-Denk Rectal contains the same active ingredient, diclofenac sodium, as other forms of the medicine. However, because it is a suppository, it is formulated with different inactive ingredients, or excipients, than an oral tablet or a topical gel. Official information describes the suppository as an alternative delivery method when oral administration is not possible.

Q: What does 'NSAID' mean in simple terms?

NSAID stands for Nonsteroidal Anti-inflammatory Drug. This classification describes medicines that work by reducing inflammation, pain, and fever in the body. The active ingredient in this medicine, diclofenac, is consistently recognized as an NSAID by health authorities.

Q: How quickly should I expect Diclo-Denk Rectal to start working?

Official product information regarding diclofenac formulations suggests that the onset of action is often reported to occur within 30 minutes of administration. The time it takes to feel the effect can vary depending on individual patient factors and the specific condition being managed.

Q: How long does the pain relief from one Diclo-Denk Rectal last?

Diclofenac has a relatively short elimination half-life, which describes the time it takes for the amount of medicine in the body to decrease by half. Official documents report this period to be around 1.2 to 2 hours. This short half-life is consistent with the typical recommended dosing intervals for the medicine.

Q: Can Diclo-Denk Rectal be used for period pain (menstrual cramps)?

Yes, regulatory-linked patient information indicates that diclofenac is sometimes used to treat painful conditions such as menstrual cramps, medically known as dysmenorrhea. The drug's primary function is to address pain and inflammation.

Q: What should I do if I forget to use a dose of Diclo-Denk Rectal?

Patient information leaflets state that it is generally recommended to skip the missed dose entirely if it is almost time for the next scheduled dose. It is strictly stated in official documents that you must never use two doses at once to make up for a forgotten one.

Q: Does using Diclo-Denk Rectal make me feel dizzy or drowsy?

Official product safety information indicates that side effects may include nervous system symptoms such as dizziness or drowsiness. These documented effects may influence the ability to safely perform activities that require mental alertness.

Q: Are there any foods or drinks I need to avoid while using Diclo-Denk Rectal?

Regulatory documents specifically note a documented interaction risk with alcohol. Consumption of alcohol is stated to increase the risk of serious gastrointestinal problems when using diclofenac. No other specific food groups are mentioned as being formally contraindicated.

Q: Will Diclo-Denk Rectal interfere with any laboratory tests?

Official product monographs state that diclofenac may cause changes in certain laboratory test results. Specifically, this medicine may affect liver function tests and can cause statistically significant changes in tests related to blood clotting, such as prothrombin and partial thromboplastin times.

Q: Can Diclo-Denk Rectal be used during pregnancy or while breastfeeding?

According to regulatory warnings, this medicine is contraindicated for use during the last three months of pregnancy as it carries a risk of harm to the unborn child. Use during the first six months is not recommended except under medical supervision when potential benefits outweigh risks. Breastfeeding is also not recommended while using this medicine, as the active ingredient passes into breast milk.

Q: What are the signs of an allergic reaction to Diclo-Denk Rectal?

Signs of a serious allergic (hypersensitivity) reaction, as documented in regulatory sources, include shortness of breath, wheezing, skin rash, and hives. Swelling of the face, throat, lips, or tongue may be signs of a serious reaction.

Q: Can I drive or operate machinery while using Diclo-Denk Rectal?

Official product monographs state that because diclofenac may cause nervous system side effects such as dizziness or drowsiness, patients who experience these effects should not operate machinery or drive.

Q: Why is this drug sometimes used after surgery?

The drug is classified as having strong analgesic (pain-relieving) and anti-inflammatory properties. Official product information specifically mentions its use in managing acute post-operative pain in certain patient populations.

Q: Why is it important to check the expiry date on Diclo-Denk Rectal suppositories?

Regulatory guidance confirms that the expiration date reflects the time period during which the product remains stable when stored correctly. This ensures the medicine retains its documented strength, quality, and purity, providing the intended effects.

Q: Does Diclo-Denk Rectal contain lactose or gluten?

The exact inactive ingredients (excipients) for the rectal form can vary, though some oral diclofenac products are known to contain lactose. It is important to check the official patient leaflet to confirm the presence of lactose or gluten, especially since restrictions exist for specific intolerances.

Q: Is it possible for Diclo-Denk Rectal to lose its effectiveness over time?

Regulatory guidance states that if a drug degrades due to improper storage or after the expiration date, it may have a lower strength than intended. In such a scenario, the product might not provide the expected therapeutic effect.

Q: What happens if a suppository melts before I can use it?

Official medication administration guidance suggests that if a suppository is soft or has melted, it can be hardened again. This can be done by holding it under cool water or briefly placing it in a refrigerator to help solidify the suppository before insertion.

Q: Can people with kidney stones use Diclo-Denk Rectal?

Official documents state that diclofenac is contraindicated for patients with severe renal (kidney) impairment or rapidly deteriorating renal disease. While kidney stones are not explicitly named, official documents note that close monitoring is generally required for patients with any impaired renal function.

Q: What is the half-life of diclofenac when administered rectally?

The elimination half-life of diclofenac, which is a measure of how quickly the medicine is cleared from the body, is described in official drug information. This period is typically reported to be approximately 1.2 to 2 hours.

Q: Does Diclo-Denk Rectal cause fluid retention or swelling?

Yes, fluid retention, or edema, is a documented side effect of diclofenac. This effect may manifest as swelling, particularly in the feet or lower legs.

Q: Can I use Diclo-Denk Rectal if I have hemorrhoids?

Official contraindications state that the medicine must not be used in the presence of inflammatory lesions of the rectum or anus, such as proctitis, or recent rectal bleeding.

Q: What kind of studies support the use of Diclo-Denk Rectal?

Efficacy is supported by results from clinical trials, which often include Phase 3, double-blind, placebo-controlled trials. These types of studies are used to generate evidence for the drug's intended uses and to assess long-term tolerability.

Q: Is there a maximum duration of time this medicine is typically used?

Regulatory guidance emphasizes that the lowest effective dose should be used for the shortest time required to control symptoms. For acute conditions, official information suggests the medicine may only be required for 1 or 2 days, and long-term use is typically undertaken with medical supervision.

Q: Are there any long-term consequences of using Diclo-Denk Rectal regularly?

Official patient information indicates that diclofenac is generally not intended for long-term use. Using the medicine regularly over a long duration increases the risk of serious side effects, including heart attack, heart failure, and stroke.

How to Store and Dispose of Diclo-Denk Rectal

The storage and disposal of Diclo-Denk Rectal suppositories must adhere strictly to official regulatory guidelines to maintain product quality and safety.

---

Official Storage Conditions

Requirement	Specific Condition
Temperature	Store below 25°C (Controlled room temperature).
Protection	Must be protected from light and kept in a dry place.
Packaging	Keep the product in its original container (blister pack).
Child Safety	Must be kept out of the reach and sight of children.
Shelf-Life	Has an official shelf life of 3 years when stored correctly.

---

Disposal Instructions

Official labeling states “No special requirements” for disposal. Unused or expired suppositories should not be discarded via household wastewater (e.g., toilet or sink) or standard household trash. Dispose of the medicine by returning it to a pharmacy or using a local pharmaceutical waste collection program, following applicable local regulations.